Amgen
Amgen Creates New Therapy Line
With its long-anticipated acquisition of Horizon Therapeutics wrapped up last month, Thousand Oaks pharma giant Amgen Inc. is incorporating Horizon’s drug development programs into a new business line for rare disease therapies. Meanwhile, along its more traditional business lines, Amgen late last month won approval from the United States Food and Drug Administration to market […]
Amgen Launches a Partner Network
Thousand Oaks-based pharmaceutical giant Amgen Inc. is putting more emphasis on its international reach. Besides its much-covered $27.8 billion acquisition of Dublin, Ireland-based Horizon Therapeutics that closed on Oct. 6, Amgen in recent months has established a network of eight cancer research centers around the globe, bringing together leaders of these centers and its own […]
Amgen CEO Decries Federal Deliberations
Robert Bradway, chief executive of Thousand Oaks pharma giant Amgen Inc., has grown increasingly frustrated at the government’s unwillingness to come to terms with Amgen over its $27.8 billion acquisition deal of Irish pharma company Horizon Therapeutics. That deal, announced last December, hit a major stumbling block in May when the Federal Trade Commission filed […]